Hence, the presence or absence of abnormal BSEP IHC results in MYO5B-associated cholestasis did not have clinical significance, and the aberrant localization of BSEP clearly was not the primary or sole mechanism responsible for MYO5B-associated cholestasis. The gene discussed is MYO5B; the disease is cholestasis.